[Funding alert] Copenhagen-based Neurescue Raises DKK 50M (approximately $7.3 million) in Series A Round Funding

West Hill Capital is an M&A, IPO, and capital raising specialist with over £20 billion in advised deals under its belt. The company raises cash in the range of £1 million to £20 million through smaller transactions.

Read also - British Biotech FA Bio Raises €6.1 Million in Funding

Neurescue claims that the present CPR technique only replenishes 35% of blood flow, which is frequently insufficient for successful resuscitation and does not allow for adequate time for more sophisticated treatments.

The survival rate from cardiac arrest, which accounts for 15-20% of all deaths, is only 1 in 10 with current therapy. Forty to fifty percent of the life years lost to cardiac illnesses in the United States are due to sudden cardiac arrest.

Read also - Dutch AI Startup Whispp Secures €750k in Seed Funding

Specialized in cardiovascular solutions, the company offers the first computer-aided balloon catheter for aortic occlusion in the world. By improving blood supply to the heart and brain, this approach seeks to extend treatment duration and boost resuscitation rates. Dr. Habib Frost created the nine-year-old company, which got FDA approval for its NEURESCUE gadget 2.5 years ago.

The catheter and control unit that make up the NEURESCUE device use automatic inflation and patented sensor guiding. Its safety feedback system controls balloon pressure to prevent damage and guarantees accurate alignment.

Read also - Lyon-based ENYO Pharma Secures a €39 Million in Series C Round Funding

About Neurescue

Neurescue, a Danish company with its headquarters in Copenhagen, provides cardiovascular equipment to enhance patient outcomes for emergency patients. The business, which created the first FDA-approved intelligent balloon system, is committed to saving hearts and minds.

Read also -  London-based Episode 1 Secures its Third Fund at £76 Million